Bivalirudin for Injection 250 mg/vial 10 mL New Product Launch

April 17, 2019

Dear Valued Customer,

Fresenius Kabi Canada is pleased to announce the launch of Bivalirudin for Injection 250 mg/vial 10 mL.
The product is bar-coded, latex free and preservative free.

This product will be available Thursday, April 18, 2019 through all MDP and McKesson locations.

Bivalirudin for Injection 250 mg/vial 10 mL

If you would like to obtain more information on this product, please contact your hospital representative or our Customer Service Department at (877) 821-7724.

Sincerely,
George Shamsoun
Product Manager – IV Drugs
george.shamsoun@fresenius-kabi.com